跳至主要内容
临床试验/EUCTR2006-002286-40-NL
EUCTR2006-002286-40-NL进行中(未招募)不适用

Chronic Pain Management after HerniorraphyPregabaline versus Placebo

Pfizer bv0 个研究点目标入组 135 人开始时间: 2006年11月24日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
135

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • 1.History of unilateral inguinal herniotomy
  • 2.Establishment of neuropathic character of chronic pain by means the LANSS painscore and DN4 score
  • 3.Abnormal sensitivity (allodynia, dysesthesia, hypoesthesia or dysesthesia) in or around the incisional area
  • 4.Duration pain = 3 months
  • 5.Gender: Male
  • 6.Medial or lateral inguinal hernia
  • 7.Age = 18 years
  • 8.Description III or IV of pain interfering with daily activity
  • 9.VAS score = 40 mm on Vas scale on which they indicate ‘how unpleasant or disturbing the worst pain was that they had today’
  • 10.Informed consent (addendum V)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Participation in another trial
  • 2.Bilateral hernia
  • 3.Recurrent hernia
  • 4.Age < 18 years
  • 5.Cognitive disfunction
  • 6.Patient is unable to speak Dutch
  • 7.Description I or II of pain interfering with daily activity
  • 8.Patient classified as American Society of Anaesthesiologist Class 4

研究者

发起方
Pfizer bv

相似试验